Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4471291
Max Phase: Preclinical
Molecular Formula: C62H74O22
Molecular Weight: 1171.25
Molecule Type: Unknown
Associated Items:
ID: ALA4471291
Max Phase: Preclinical
Molecular Formula: C62H74O22
Molecular Weight: 1171.25
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1c(C)c(OC(=O)c2c(C)c(C)c(OC(=O)c3c(C)c(C(=O)Oc4c(C)c(C)c(C(=O)Oc5c(C)c(C)c(C(=O)OC(OC)OC)c(OC)c5C)c(OC)c4C)c(OC)c(C)c3OC)c(C)c2OC)c(C)c(C)c1C(=O)OC(OC)OC
Standard InChI: InChI=1S/C62H74O22/c1-25-29(5)47(34(10)49(69-15)39(25)55(63)79-45-31(7)27(3)41(51(71-17)36(45)12)59(67)83-61(75-21)76-22)81-57(65)43-33(9)44(54(74-20)38(14)53(43)73-19)58(66)82-48-30(6)26(2)40(50(70-16)35(48)11)56(64)80-46-32(8)28(4)42(52(72-18)37(46)13)60(68)84-62(77-23)78-24/h61-62H,1-24H3
Standard InChI Key: DCLKCTSNUKUFFY-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1171.25 | Molecular Weight (Monoisotopic): 1170.4672 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Ohsawa K, Yoshida M, Izumikawa M, Takagi M, Shin-Ya K, Goshima N, Hirokawa T, Natsume T, Doi T.. (2018) Synthesis and biological evaluation of thielocin B1 analogues as protein-protein interaction inhibitors of PAC3 homodimer., 26 (23-24): [PMID:30455074] [10.1016/j.bmc.2018.11.001] |
Source(1):